Last reviewed · How we verify
Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Enoxaparin Sodium（RP54563）20mg qd and 20mg Bid for 14 Days in Patients With Total Hip Replacement
This study is performed to confirm the optimal dose for THR (total hip replacement).
Details
| Lead sponsor | Sanofi |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 156 |
| Start date | 2006-06 |
Conditions
- Arthroplasty, Replacement, Hip
Interventions
- Enoxaparin sodium
Primary outcomes
- Incidence of VTE
Countries
Japan